-
MrgX2 antagonists
-
Patent number 11,976,057
-
Issue date May 7, 2024
-
GlaxoSmithKline Intellectual Property Development Limited
-
Edward Brnardic
-
C07 - ORGANIC CHEMISTRY
-
-
TRPV4 antagonists
-
Patent number 11,229,623
-
Issue date Jan 25, 2022
-
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
-
Edward J. Brnardic
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
TRPV4 antagonist
-
Patent number 10,968,209
-
Issue date Apr 6, 2021
-
GlaxoSmithKline Intellectual Property (No. 2) Limited
-
Patrick Stoy
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
TRPV4 antagonists
-
Patent number 10,588,891
-
Issue date Mar 17, 2020
-
GlaxoSmithKline Intellectual Property Development Limited
-
Edward J. Brnardic
-
A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
-
-
TRPV4 antagonists
-
Patent number 9,487,507
-
Issue date Nov 8, 2016
-
GlaxoSmithKline Intellectual Property (No. 2) Limited
-
Carl Brooks
-
C07 - ORGANIC CHEMISTRY
-
TRPV4 antagonists
-
Patent number 9,187,464
-
Issue date Nov 17, 2015
-
GlaxoSmithKline Intellectual Property (No. 2) Limited
-
Carl Brooks
-
C07 - ORGANIC CHEMISTRY
-
TRPV4 antagonists
-
Patent number 8,658,636
-
Issue date Feb 25, 2014
-
GlaxoSmithKline, LLC
-
Carl A. Brooks
-
C07 - ORGANIC CHEMISTRY